
The Latest Updates in BTK Inhibitors – Episode 210
In this research update, Stephanie Buxhoeveden explores the latest developments in BTK inhibitors. She breaks down recent clinical trial results, promising findings on smoldering MS, differences in medication safety, and what regulatory decisions mean for the future of treatment.
What could these medications mean for people living with MS? Join Stephanie to learn what’s promising, what’s still uncertain, and what these advances could mean for MS care.
Disclaimer: This podcast provides general educational information. Can Do MS does not endorse, promote, or recommend any product or service associated with the content of this program.
Altri episodi di "Can Do MS Podcast"



Non perdere nemmeno un episodio di “Can Do MS Podcast”. Iscriviti all'app gratuita GetPodcast.








